SCHEMBL19303185

SCHEMBL19303185

C=N/C(O)=C\c1cccc(Cl)c1C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ POLB P06746 2/20 0.35
▸ LMNA P02545 4/20 0.33
▸ MAPT P10636 3/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ MT-CO2 P00403 1/20 0.33
▸ TTR P02766 1/20 0.33
▸ PLA2G1B P04054 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ PGR P06401 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ HTR1A P08908 1/20 0.33
▸ ADRA2A P08913 1/20 0.33
▸ ADORA3 P0DMS8 1/20 0.33
▸ AR P10275 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HTR2A P28223 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21622907 0.78 ALDH1A1 (0.42) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL30340515 0.78 ALDH1A1 (0.42) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL8604093 0.73 ALDH1A1 (0.41) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL1532661 0.71 ALDH1A1 (0.60) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL16955594 0.71 ALDH1A1 (0.46) ALDH1A1POLBLMNAMAPTMEN1
Formaldoxime SCHEMBL29083081 0.71 ALDH1A1 (0.50) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL17064025 0.71 ALDH1A1 (0.46) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL17064023 0.71 ALDH1A1 (0.46) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL3716769 0.69 ALDH1A1 (0.48) ALDH1A1POLBLMNAMAPTMEN1
SCHEMBL19332421 0.68 LMNA (0.34) ALDH1A1LMNAMAPTMEN1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170247393-A1 Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2017-08-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247393-A1 Aminoisoxazoline Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 ALDH1A1 2907/4885POLB 3948/4885LMNA 1872/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback